Home › Funds › Convergence Investment Partners, LLC › EXEL
Convergence Investment Partners, LLC position in EXEL
EXELIXIS INC · Health Care
Convergence Investment Partners, LLC reported holding 142,747 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 0.62% of its reported portfolio and ranking #41 among its reported holdings. Convergence Investment Partners, LLC has disclosed EXEL holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Convergence Investment Partners, LLC's EXEL position evolved
Convergence Investment Partners, LLC first disclosed a stake in EXEL in Q4 2024 at 23,488 shares (US$782K). The position peaked in Q3 2026 at 142,747 shares, worth US$8.3M. Across 7 filings, Convergence Investment Partners, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 142,747 shares valued at US$8.3M — an increase of 31,178 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2025 (shares rose 20% over the following quarter), a 44% increase in Q1 2026 (shares rose 28% over the following quarter), a 60% increase in Q2 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 23.49K | $782.15K | New |
| Q1 2025 | 37.01K | $1.37M | Add |
| Q2 2025 | 38.11K | $1.68M | Add |
| Q4 2025 | 48.29K | $2.12M | New |
| Q1 2026 | 69.62K | $2.99M | Add |
| Q2 2026 | 111.57K | $6.07M | Add |
| Q3 2026 | 142.75K | $8.34M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Renaissance Technologies 12.79M sh · $747.22M · Q3 2026
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M sh · $732.79M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M sh · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.60M sh · $151.65M · Q3 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on Convergence Investment Partners, LLC
FAQ
How long has Convergence Investment Partners, LLC held EXEL?
Convergence Investment Partners, LLC has disclosed EXEL holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
What is Convergence Investment Partners, LLC's current position in EXEL?
As of Q3 2026, Convergence Investment Partners, LLC holds 142.75K shares of EXEL (EXELIXIS INC), valued at $8.34M, representing 0.62% of its reported portfolio and ranking #41.
Has Convergence Investment Partners, LLC been buying or selling EXEL?
In the latest 13F filing (Q3 2026), Convergence Investment Partners, LLC increased its position in EXEL. The position peaked in Q3 2026 at 142.75K shares.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.